The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, ...

Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

Flexential, a leading provider of secure and flexible data center solutions, has been included in the Data Center 50 list by ...

2bcloud is a global managed service provider (MSP) that helps tech companies optimize their cloud infrastructure and costs. By transferring your cloud bill to us, you get an unparalleled Complete ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.

Pfizer has partnered with Summit Therapeutics to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with ...

A packed audience at Sydney’s International Convention Centre for a UIA Gala event last night, heard Rachel Goldberg and Jon ...